In a long-anticipated move, this past Wednesday GE spun out its healthcare division with a listing on the NASDAQ stock exchange. After […]
Posts Tagged ‘ABUS’
ABUS Firm Raises Another $30 Million
Delphinus Medical Technologies has just announced the closing of a $30 million investment to fast-track commercialisation of its SoftVue automated breast ultrasound […]
Reducing Breast Cancer Deaths in Low-Income Countries
Each year, 2.3 million women worldwide are diagnosed with breast cancer, while there are 685,000 deaths. Two-thirds of these deaths occur in middle- and […]
Inspired by an Ancient Queen
A decade ago, Siddhartha Mukherjee published his prize-winning book entitled The Emperor of All Maladies: A Biography of Cancer. He quoted from […]
Another US Patent for CapeRay
Five years ago, we reported that the United States Patent and Trademark Office (USPTO) had awarded CapeRay a key patent to protect our novel dual-modality […]
AI for Breast Ultrasound
On 23 December 2021, the board of directors of RSNA announced that Dr Linda Moy (seen right) would become editor of their […]
ABUS and DBT and FFDM
It was five years ago that we published a key article in Diagnostics, an open-access journal, in which we described our dual-modality […]
Understanding Breast Density
The Merriam-Webster dictionary provides three essential meanings for the word “density”: having parts that are close together; being difficult to see through; […]
Ultrasound to the Fore
The online magazine AuntMinnie.com has just published a review article by Emily Hayes entitled “Ultrasound jostles for bigger role in screening dense breasts.” With […]
Evaluating DBT after 10 Years
Earlier this year, we described how the digital breast tomosynthesis (DBT) pioneers, led by Dr Daniel Kopans, developed a screening tool that […]